{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:19:34Z","timestamp":1777673974809,"version":"3.51.4"},"reference-count":19,"publisher":"Societas Neurologica Japonica","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rinsho Shinkeigaku"],"published-print":{"date-parts":[[2013]]},"DOI":"10.5692\/clinicalneurol.53.809","type":"journal-article","created":{"date-parts":[[2013,11,12]],"date-time":"2013-11-12T23:06:42Z","timestamp":1384297602000},"page":"809-813","source":"Crossref","is-referenced-by-count":4,"title":["A case of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) with treatment-resistant status epilepticus that was effectively treated with lamotrigine"],"prefix":"10.5692","volume":"53","author":[{"given":"Toru","family":"Kai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichiro","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyasu","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeaki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsui","family":"Nagado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3663","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Iizuka T, Sakai F. Pathophysiology of stroke-like episodes in MELAS: neuron-astrocyte uncoupling in neuronal hyperexcitability. Future Neurol 2010;5:61-83.","DOI":"10.2217\/fnl.09.71"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Tsujikawa T, Yoneda M, Shimizu Y, et al. Pathophysiologic evaluation of MELAS strokes by serially quantified MRS and CASL perfusion images. Brain Dev 2010;32:143-149.","DOI":"10.1016\/j.braindev.2008.12.003"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Iizuka T, Sakai F, Suzuki N, et al. Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome. Neurology 2002;59:816-824.","DOI":"10.1212\/WNL.59.6.816"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Iizuka T, Sakai F, Kan S, et al. Slowly progressive spread of the stroke-like lesions in MELAS. Neurology 2003;61:1238-1244.","DOI":"10.1212\/01.WNL.0000091888.26232.FE"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Iizuka T, Sakai F. Pathogenesis of stroke-like episodes in MELAS: analysis of neurovascular cellular mechanisms. Curr Neurovasc Res 2005;2:29-45.","DOI":"10.2174\/1567202052773544"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Koga Y, Akita Y, Nishioka J, et al. MELAS and L-arginine therapy. Mitochondrion 2007;7:133-139.","DOI":"10.1016\/j.mito.2006.11.006"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Finsterer J, Barton P. Regression of stroke-like lesions in MELAS-syndrome after seizure control. Epileptic Disord 2010;12:330-334.","DOI":"10.1684\/epd.2010.0338"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Ohama E, Ohara S, Ikuta F, et al. Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol 1987;74:226-233.","DOI":"10.1007\/BF00688185"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Clark JM, Marks MP, Adalsteinsson E, et al. MELAS: Clinical and pathologic correlations with MRI, xenon\/CT, and MR spectroscopy. Neurology 1996;46:223-227.","DOI":"10.1212\/WNL.46.1.223"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Koga Y, Akita Y, Nishioka J, et al. L-arginine improves the symptoms of strokelike episodes in MELAS. Neurology 2005;64:710-712.","DOI":"10.1212\/01.WNL.0000151976.60624.01"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Sparaco M, Bonilla E, DiMauro S, et al. Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects. J Neuropathol Exp Neurol 1993;52:1-10.","DOI":"10.1097\/00005072-199301000-00001"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kaufmann P, Shungu DC, Sano MC, et al. Cerebral lactic acidosis correlates with neurological impairment in MELAS. Neurology 2004;62:1297-1302.","DOI":"10.1212\/01.WNL.0000120557.83907.A8"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Koga Y, Akita Y, Junko N, et al. Endothelial dysfunction in MELAS improved by l-arginine supplementation. Neurology 2006;66:1766-1769.","DOI":"10.1212\/01.wnl.0000220197.36849.1e"},{"key":"14"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Difrancesco JC, Cooper JM, Lam A, et al. MELAS mitochondrial DNA mutation A3243G reduces glutamate transport in cybrids cell lines. Exp Neurol 2008;212:152-156.","DOI":"10.1016\/j.expneurol.2008.03.015"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Xie X, Lancaster B, Peakman T, et al. Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na<sup>+<\/sup> channels and with native Na<sup>+<\/sup> channels in rat hippocampal neurones. Pflugers Arch 1995;430:437-446.","DOI":"10.1007\/BF00373920"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Wang SJ, Huang CC, Hsu KS, et al. Inhibition of N-type calcium currents by lamotrigine in rat amygdalar neurones. Neuroreport 1996;7:3037-3040.","DOI":"10.1097\/00001756-199611250-00048"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Sitges M, Chiu LM, Guarneros A, et al. Effects of carbamazepine, phenytoin, lamotrigine, oxcarbazepine, topiramate and vinpocetine on Na<sup>+<\/sup> channel-mediated release of [3H]glutamate in hippocampal nerve endings. Neuropharmacology 2007;52:598-605.","DOI":"10.1016\/j.neuropharm.2006.09.002"},{"key":"19"}],"container-title":["Rinsho Shinkeigaku"],"original-title":["\u6cbb\u7642\u62b5\u6297\u6027\u306e\u3066\u3093\u304b\u3093\u91cd\u7a4d\u306b\u5bfe\u3057\u3066\u30e9\u30e2\u30c8\u30ea\u30ae\u30f3\u304c\u594f\u52b9\u3057\u305fmitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes\uff08MELAS\uff09\u306e1\u4f8b"],"language":"en","deposited":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T11:32:33Z","timestamp":1716118353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/clinicalneurol\/53\/10\/53_809\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.5692\/clinicalneurol.53.809","relation":{},"ISSN":["0009-918X","1882-0654"],"issn-type":[{"value":"0009-918X","type":"print"},{"value":"1882-0654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}